ARA-290 (Cibinetide) vs MK-677 (Ibutamoren)
ARA-290 (Cibinetide): Investigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.
MK-677 (Ibutamoren): Oral GH secretagogue that cranks appetite, muscle preservation, and bone density.
ARA-290 (Cibinetide)
RecoveryInvestigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.
Top benefits
- Activates the innate repair receptor to promote tissue protection and healing
- Reduced neuropathic pain symptoms in sarcoidosis small-fiber neuropathy trials
- Increased corneal nerve fiber measures (a marker of small-nerve regeneration) without raising hematocrit
MK-677 (Ibutamoren)
PerformanceOral GH secretagogue that cranks appetite, muscle preservation, and bone density.
Top benefits
- Increases muscle mass
- Improves bone density
- Improves sleep quality
- Oral administration
| Attribute | ARA-290 (Cibinetide) | MK-677 (Ibutamoren) |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | small-molecule |
| Chain length | 11 aa | 1 aa |
| Formula | helix-B 11-mer (non-erythropoietic EPO derivative) | C27H36N4O5S |
| Common dose | 2 mg IV or 1-8 mg SC | 10-25 mg |
| Frequency | Three times weekly to daily (per trial) | Daily |
| Top benefit | Activates the innate repair receptor to promote tissue protection and healing | Increases muscle mass |
| Top side-effect | Generally well tolerated in trials | Increased appetite |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.